Literature DB >> 18437387

Systemic sclerosis associated with generalized vasculitis and hypopituitarism.

John C Katsantonis1, John Protopsaltis, Stelios Kokkoris, Paris Brestas, Kyriaki Aroni, Symeon Tournis, Gregory Giannoulis.   

Abstract

Systemic sclerosis (SSc) is a progressively evolving multisystemic disorder of unknown etiology. Beyond skin, several other organs can also be affected with a severity of involvement that is often heterogeneous. We describe a 53-year-old female patient who was admitted urgently to the hospital almost collapsed, because of numerous bleeding deep skin ulcers, located all over the body. Clinical findings and autoantibody screening were typical of SSc. Moreover, both histopathology and immunofluorescence findings were compatible with scleroderma and vasculitis as well. In addition, pituitary hormone investigation revealed severely damaged function of the gland. We assume that severe skin ulceration and serious hypopituitarism were both implications of underlying SSc-associated vasculitis. To the best of our knowledge, these peculiar clinical manifestations have not been described in the international literature to date.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18437387     DOI: 10.1007/s00296-008-0586-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  14 in total

1.  Thyroid hormones in generalized scleroderma. A controlled study.

Authors:  J Serup; H Hangdrup
Journal:  Acta Derm Venereol       Date:  1986       Impact factor: 4.437

2.  Thyroid dysfunction in a prospectively followed series of patients with progressive systemic sclerosis.

Authors:  L De Keyser; D C Narhi; D E Furst; A K Huberman; R Ross; J Clements; A J Van Herle
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

3.  Evidence of cerebral hypoperfusion in scleroderma patients.

Authors:  M Cutolo; F Nobili; A Sulli; C Pizzorni; M Briata; F Faelli; P Vitali; G Mariani; F Copello; B Seriolo; C Barone; G Rodriguez
Journal:  Rheumatology (Oxford)       Date:  2000-12       Impact factor: 7.580

4.  Scleroderma and central nervous system vasculitis.

Authors:  R Pathak; A J Gabor
Journal:  Stroke       Date:  1991-03       Impact factor: 7.914

5.  Successful treatment of an extended leg ulcer in systemic sclerosis.

Authors:  J Hafner; A Kohler; M Enzler; U Brunner
Journal:  Vasa       Date:  1997-11       Impact factor: 1.961

6.  [Scleroderma with anomalies of the thyroid function. 7 cases].

Authors:  E Ghayad; A Tohme; F Haddad; C Haddad; R Choueiry
Journal:  Ann Med Interne (Paris)       Date:  1997

7.  Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: the importance of concomitant arterial and venous disease.

Authors:  J Hafner; E Schneider; G Burg; P C Cassina
Journal:  J Vasc Surg       Date:  2000-08       Impact factor: 4.268

8.  Prolactin and thyroid hormones in patients with systemic sclerosis: correlations with disease manifestations and activity.

Authors:  A A Shahin; S Abdoh; M Abdelrazik
Journal:  Z Rheumatol       Date:  2002-12       Impact factor: 1.372

9.  Psychotic episodes in an elderly woman with an anticentromere-positive scleroderma variant, IgA deficiency, and hypothyroidism.

Authors:  A H Schmid; B R Meltzer
Journal:  J Geriatr Psychiatry Neurol       Date:  1994 Apr-Jun       Impact factor: 2.680

10.  Multiple spontaneous intracerebral hemorrhages in a patient with progressive systemic sclerosis.

Authors:  A P Andonopoulos; T Maraziotis; G Rigas; S Yarmenitis; T Papapetropoulos
Journal:  Rev Rhum Engl Ed       Date:  1998-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.